Literature DB >> 11953375

Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.

Hiroyuki Yamaguchi1, Shusaku Haranaga, Ray Widen, Herman Friedman, Yoshimasa Yamamoto.   

Abstract

Migration and differentiation of monocytes to the intima of blood vessels may be a crucial first step in the development of atherosclerosis associated with Chlamydia (Chlamydophila) pneumoniae. However, the involvement of C. pneumoniae infection in such steps is not clear. In the present study, therefore, the differentiation-inducing activity of C. pneumoniae to monocytes was examined. Human THP-1 monocytic cell line cells were infected with C. pneumoniae, and the differentiation of monocytes to macrophages was assessed by cell morphology, phagocytic activity, and expression of a cell surface adhesion molecule. The monocytic cells infected with viable bacteria markedly differentiated into macrophages associated with diffused cell morphology, increased uptake of polystyrene beads and increased ICAM-1 (intercellular adhesion molecule 1) expression on the cell surfaces. Heat-killed bacteria did not induce any morphological changes or increase of phagocytosis, but they did induce an increase of cell surface ICAM-1 expressions in THP-1 monocytic cells. The antibiotic minocycline treatment of infected cells resulted in marked inhibition of the cell differentiation as well as C. pneumoniae growth in the cells, but not ICAM-1 expression. In addition, the experiments with human peripheral blood monocytes infected with C. pneumoniae also showed the differentiation of macrophages assessed by morphological change and phagocytic activity. These results indicate that C. pneumoniae infection may directly induce the differentiation of monocytes to macrophages. However, antigenic stimulation of monocytes with bacteria may not be sufficient for a full macrophage differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953375      PMCID: PMC127917          DOI: 10.1128/IAI.70.5.2392-2398.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Chlamydia pneumoniae in atherosclerosis.

Authors:  P Saikku
Journal:  J Intern Med       Date:  2000-03       Impact factor: 8.989

Review 2.  The role of Chlamydia pneumoniae in atherosclerosis--recent evidence from animal models.

Authors:  L A Campbell; M Rosenfeld; C C Kuo
Journal:  Trends Microbiol       Date:  2000-06       Impact factor: 17.079

3.  Chlamydia pneumoniae detection in atherosclerotic plaques in Italy.

Authors:  F Blasi; L Fagetti; L Allegra
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

4.  Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.

Authors:  E A Castilla; R M Wadowsky
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.

Authors:  S Gessani; U Testa; B Varano; P Di Marzio; P Borghi; L Conti; T Barberi; E Tritarelli; R Martucci; D Seripa
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

6.  Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction.

Authors:  G Esposito; F Blasi; L Allegra; R Chiesa; G Melissano; R Cosentini; P Tarsia; L Dordoni; C Cantoni; C Arosio; L Fagetti
Journal:  Ann Vasc Surg       Date:  1999-07       Impact factor: 1.466

7.  A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.

Authors:  A Gross; A Terraza; J Marchant; M Bouaboula; S Ouahrani-Bettache; J P Liautard; P Casellas; J Dornand
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

8.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

Authors:  F Blasi; F Denti; M Erba; R Cosentini; R Raccanelli; A Rinaldi; L Fagetti; G Esposito; U Ruberti; L Allegra
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

9.  Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10.

Authors:  Y Geng; R B Shane; K Berencsi; E Gonczol; M H Zaki; D J Margolis; G Trinchieri; A H Rook
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

10.  Frequent contamination of Chlamydia trachomatis and Chlamydia pneumoniae strains with mycoplasma. Biological relevance and selective eradication of mycoplasma from chlamydial cultures with mupirocin.

Authors:  B Krausse-Opatz; P Dollmann; H Zeidler; J G Kuipers; L Köhler
Journal:  Med Microbiol Immunol       Date:  2000-09       Impact factor: 3.402

View more
  11 in total

Review 1.  Immunopathological aspects of age-related macular degeneration.

Authors:  Mrinali Patel; Chi-Chao Chan
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

2.  Shear Stress Enhances Chemokine Secretion from Chlamydia pneumoniae-infected Monocytes.

Authors:  Shankar J Evani; Shatha F Dallo; Ashlesh K Murthy; Anand K Ramasubramanian
Journal:  Cell Mol Bioeng       Date:  2013-09-01       Impact factor: 2.321

3.  Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.

Authors:  E Podsiadły; J Przyłuski; A Kwiatkowski; M Kruk; M Wszoła; R Nosek; W Rowiński; W Ruzyłło; S Tylewska-Wierzbanowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

4.  Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages.

Authors:  Lei Zhou; Ling-Hong Shen; Liu-Hua Hu; Heng Ge; Jun Pu; Da-Jun Chai; Qin Shao; Li Wang; Jin-Zhang Zeng; Ben He
Journal:  Mol Cell Biochem       Date:  2009-09-27       Impact factor: 3.396

5.  Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci.

Authors:  Shankar J Evani; Anand K Ramasubramanian
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

6.  Thrombomodulin regulates monocye differentiation via PKCδ and ERK1/2 pathway in vitro and in atherosclerotic artery.

Authors:  Chien-Sung Tsai; Yi-Wen Lin; Chun-Yao Huang; Chun-Min Shih; Yi-Ting Tsai; Nai-Wen Tsao; Chin-Sheng Lin; Chun-Che Shih; Hellen Jeng; Feng-Yen Lin
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

7.  20S-dihydroprotopanaxadiol, a ginsenoside derivative, boosts innate immune responses of monocytes and macrophages.

Authors:  Mi-Yeon Kim; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2013-07       Impact factor: 6.060

8.  Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses.

Authors:  Shahzada Khan; H N Ashiqur Rahman; Tatsuya Okamoto; Tetsuro Matsunaga; Yukio Fujiwara; Tomohiro Sawa; Jun Yoshitake; Katsuhiko Ono; Khandaker Ahtesham Ahmed; Md Mizanur Rahaman; Kohta Oyama; Motohiro Takeya; Tomoaki Ida; Yoshiaki Kawamura; Shigemoto Fujii; Takaaki Akaike
Journal:  Sci Rep       Date:  2014-04-15       Impact factor: 4.379

9.  20S-dihydroprotopanaxatriol modulates functional activation of monocytes and macrophages.

Authors:  Mi-Yeon Kim; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2013-07       Impact factor: 6.060

10.  Gingipains from Porphyromonas gingivalis play a significant role in induction and regulation of CXCL8 in THP-1 cells.

Authors:  Kartheyaene Jayaprakash; Hazem Khalaf; Torbjörn Bengtsson
Journal:  BMC Microbiol       Date:  2014-07-18       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.